These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 25059564

  • 1. Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy.
    Ding S, Huang W, Ye Y, Yang J, Hu J, Wang X, Liu L, Lu Q, Lin Y.
    Mol Med Rep; 2014 Sep; 10(3):1215-24. PubMed ID: 25059564
    [Abstract] [Full Text] [Related]

  • 2. Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitration.
    Ding S, Yang J, Liu L, Ye Y, Wang X, Hu J, Chen B, Zhuge Q.
    Int J Biochem Cell Biol; 2014 Oct; 55():252-63. PubMed ID: 25220477
    [Abstract] [Full Text] [Related]

  • 3. Dopamine induces glutamate accumulation in astrocytes to disrupt neuronal function leading to pathogenesis of minimal hepatic encephalopathy.
    Ding S, Wang X, Zhuge W, Yang J, Zhuge Q.
    Neuroscience; 2017 Dec 04; 365():94-113. PubMed ID: 28965835
    [Abstract] [Full Text] [Related]

  • 4. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
    Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, Felipo V.
    J Mol Med (Berl); 2007 Mar 04; 85(3):237-45. PubMed ID: 17216205
    [Abstract] [Full Text] [Related]

  • 5. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M, Chrapusta SJ, Lukačova N, Langfort J.
    Brain Res; 2015 Aug 27; 1618():29-40. PubMed ID: 26006108
    [Abstract] [Full Text] [Related]

  • 6. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 27; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 7. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
    Rodrigo R, Montoliu C, Chatauret N, Butterworth R, Behrends S, Del Olmo JA, Serra MA, Rodrigo JM, Erceg S, Felipo V.
    Neurochem Int; 2004 Nov 27; 45(6):947-53. PubMed ID: 15312989
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study.
    Marcoli M, Maura G, Cervetto C, Giacomini C, Oliveri D, Candiani S, Pestarino M.
    Neurochem Int; 2006 Dec 27; 49(7):683-90. PubMed ID: 16904241
    [Abstract] [Full Text] [Related]

  • 9. Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy.
    Ding S, Liu L, Jing H, Xie J, Wang X, Mao J, Chen B, Zhuge Q.
    Hepatol Int; 2013 Jul 27; 7(3):923-36. PubMed ID: 26201931
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA, García A.
    J Neurochem; 1999 Nov 27; 73(5):2149-57. PubMed ID: 10537075
    [Abstract] [Full Text] [Related]

  • 11. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD, Xu ZJ, Hu XG, Wu CY, Dai YR, Yang L.
    Cell Biochem Funct; 2012 Jun 27; 30(4):279-85. PubMed ID: 22290599
    [Abstract] [Full Text] [Related]

  • 12. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
    Hermenegildo C, Montoliu C, Llansola M, Muñoz MD, Gaztelu JM, Miñana MD, Felipo V.
    Eur J Neurosci; 1998 Oct 27; 10(10):3201-9. PubMed ID: 9786213
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors.
    Marcoli M, Cervetto C, Paluzzi P, Guarnieri S, Raiteri M, Maura G.
    Neurochem Int; 2006 Jul 27; 49(1):12-9. PubMed ID: 16469416
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP.
    Wykes V, Bellamy TC, Garthwaite J.
    J Neurochem; 2002 Oct 27; 83(1):37-47. PubMed ID: 12358727
    [Abstract] [Full Text] [Related]

  • 15. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
    Teunissen CE, Steinbusch HW, Markerink-van Ittersum M, De Bruijn C, Axer H, De Vente J.
    Brain Res Dev Brain Res; 2000 Dec 29; 125(1-2):99-115. PubMed ID: 11154766
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-2 (GLP-2) modulates the cGMP signalling pathway by regulating the expression of the soluble guanylyl cyclase receptor subunits in cultured rat astrocytes.
    Velázquez E, Blázquez E, Ruiz-Albusac JM.
    Mol Neurobiol; 2012 Oct 29; 46(2):242-50. PubMed ID: 22806360
    [Abstract] [Full Text] [Related]

  • 17. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.
    Bai Y, Ye S, Mortazavi R, Campese V, Vaziri ND.
    Am J Physiol Renal Physiol; 2007 Mar 29; 292(3):F974-80. PubMed ID: 17122386
    [Abstract] [Full Text] [Related]

  • 18. Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms.
    Llansola M, Montoliu C, Boix J, Felipo V.
    Chem Res Toxicol; 2010 Apr 19; 23(4):813-20. PubMed ID: 20297801
    [Abstract] [Full Text] [Related]

  • 19. Expression of soluble guanylyl cyclase in rat cerebral cortex during postnatal development.
    Ding JD, Burette A, Weinberg RJ.
    J Comp Neurol; 2005 May 09; 485(3):255-65. PubMed ID: 15791641
    [Abstract] [Full Text] [Related]

  • 20. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis.
    Van Crombruggen K, Van Nassauw L, Demetter P, Cuvelier C, Timmermans JP, Lefebvre RA.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):337-49. PubMed ID: 18022154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.